IL33 and colitis: Sedhom’s experiments using DSS and TNBS-induced colitis models in ST2−/− mice (C57BL/6J) demonstrated that IL-33 has a detrimental effect on intestinal epithelial cells, increasing their permeability and bacterial translocation and leading to more severe intestinal inflammation (Figure 3A) [27].